8:15-8:30 |
Welcome and Introductions |
8:30-9:00 |
Overview of the Bioelectronic Medicine Industry James Cavuoto, Editor, Neurotech Reports
BioElectRx Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including key players, technological roots, and market projections. |
9:00-9:30 |
Keynote Address
Thomas Oxley, M.D., Ph.D., CEO, Synchron
An industry executive offers their views on innovation and technology. |
9:30-10:15 |
Investment in Bioelectronic Medicine
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
David Neustaedter, Ph.D. Venture Partner, Deerfield Management
Greg Kubin, General Partner, PsyMed Ventures
Martin Alexander Gershon, M.D., Managing Partner and CIO, Endeavor Venture Fund & Venture Studio
In this session, investment professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine. |
10:15-10:45 |
Refreshment Break |
10:45-11:30 |
Entrepreneur Panel I
James Cavuoto, Editor, Neurotech Reports, Moderator
Dane Andreeff, CEO, Helius Medical Technologies
Nader Yaghoubi, M.D., Ph.D., Co-Founder and CEO, PathMaker Neurosystems
Kial Gramley, Chief Product Officer, Backstop Neural
Presentations from executives of emerging bioelectronic medicine firms. |
11:30-12:15 |
The Market for Treating Inflammatory Disorders
Victor Pikov, Ph.D., Contributing Editor, BioElectRx Business Report, Moderator
Benjamin Sahn, M.D., Assistant Professor, Hofstra/Northwell and Feinstein Institutes for Medical Research
Imanuel Lerman, M.D., Professor, UC San Diego
Amy Baxter, M.D., CEO, Harmonic Pain Solutions
Several vendors of implanted and noninvasive bioelectronic medicine devices are getting closer to commercialization. In this session, we'll take a look at how this new market is shaping up. |
12:15-1:15 |
Luncheon
|
1:15-1:30 |
Luncheon Speaker
Will Pitkin, Senior Director of Business Development and Neuromodulation Strategy, Cirtec Medical
|
1:30-2:15 |
Partnering with Research Institutions
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
James Zanewicz, Chief Business Officer, Tulane University of Medicine
Marc Sedam, Vice President of Technology Opportunities & Ventures, NYU Langone Health
Kip Ludwig, Ph.D., Co-Director, Wisconsin Institute for Translational Neuroengineering
Established firms and startups alike stand to benefit greatly from relationships with research institutions in the U.S. and abroad. In this session, we'll explore some of examples of profitable relationships in this field and offer advice for both invetigators and entrepreneurs |
2:15-3:00 |
Entrepreneur Panel II
JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator
Chris Czura, Ph.D., Senior Director of Scientific Affairs, Five Liters
Colin Kealey, M.D., President and CEO, NeuroSigma Inc.
Dan Rizzuto, Ph.D., CEO Nia Therapeutics
Presentations from executives of emerging bioelectronic medicine firms. |
3:00-3:30 |
Refreshment Break |
3:30-4:15 |
Entrepreneur Panel III
Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator
Ken Mariash, CEO, Sinaptica Therapeutics
Nicolas Vachicouras, Ph.D., Neurosoft Bioelectronics
Luca Ravagnan, Ph.D., CEO, WISE srl
Presentations from executives of emerging bioelectronic medicine firms. |
4:15-5:00 |
New Targets, New Indications
James Cavuoto, Editor, Neurotech Reports, Moderator
Nandan Lad, M.D., Ph.D., Vice Chair of Innovation, Duke Neurosurgery
Corey Hunter, M.D., Assistant Clinical Professor, Mount Sinai Medical Center
Marom Bikson, Ph.D., Professor, CCNY
Bioelectronic medicine researchers and vendors are exploring a number of new application areas for bioelectronic medicine that exploit several new anatomical targets. In this closing session, we'll explore some of the most promising areas of future product development and discuss the steps required to bring them to market successfully |
5:00-6:30 |
Cocktail Reception
|
|
|